Glioma Treatment Market Scope And Analysis

  • Report Code : TIPRE00029993
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 182
Buy Now

Glioma Treatment Market Size and Scope by 2031

Buy Now

Glioma Treatment Market Report Glioma Treatment Market Size and Share Glioma Treatment Market Scope and Analysis

Glioma Treatment Market Report Scope

Report Attribute Details
Market size in 2022 US$ 4.14 Billion
Market Size by 2030 US$ 8.29 Billion
Global CAGR (2022 - 2030) 9.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Disease
  • Astrocytoma
  • Oligoastrocytoma
  • Oligodendroglioma
By Treatment Type
  • Surgery
  • Chemotherapy
  • Radiation Therapy
By Grade
  • Low Grade and High Grade
By End User
  • Hospital & Clinics and Ambulatory Surgical Center
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • F Hoffmann La Roche Ltd
  • Arbor Pharmaceuticals LLC
  • Merck and Co Inc
  • Sun Pharmaceutical Industries Ltd
  • Amgen Inc
  • Teva Pharmaceutical Industries Ltd
  • Pfizer Inc
  • Amneal Pharmaceuticals LLC
  • Karyopharm Therapeutics Inc